miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients

Ovarian cancer (OC) remains a leading cause of gynecological cancer‐related death worldwide, characterized by poor 5‐year survival. Molecular markers could serve as crucial tools of personalized prognosis and therapy. Herein, we present miR‐181a as novel predictor of OC prognosis, using five indepen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International Journal of Cancer Jg. 147; H. 12; S. 3560 - 3573
Hauptverfasser: Panoutsopoulou, Konstantina, Avgeris, Margaritis, Magkou, Paraskevi, Mavridis, Konstantinos, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Reinthaller, Alexander, Michaelidou, Kleita, Mahner, Sven, Vergote, Ignace, Loverix, Liselore, Braicu, Ioana, Sehouli, Jalid, Zeillinger, Robert, Magdolen, Viktor, Scorilas, Andreas
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Hoboken, USA Wiley 15.12.2020
John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Schlagworte:
ISSN:0020-7136, 1097-0215, 1097-0215
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!